10-Year Study: Back Pain Patients Report Sustained Improvements, Decreased Reliance on Pharmaceuticals Following Medical Cannabis Treatment

A comprehensive 10-year clinical study demonstrates that medical cannabis therapy produces significant and sustained benefits for chronic back pain patients. The research shows remarkable reductions in opioid use (89.8%), pain intensity (84.2%), and functional disability (30.4%), highlighting cannabis as a viable alternative to traditional pharmaceutical interventions. These findings are particularly significant given the ongoing opioid crisis and the associated risks of long-term pharmaceutical dependence. The study's extended duration provides compelling evidence that medical cannabis treatment offers durable therapeutic effects rather than temporary relief. For Puerto Rico patients managing chronic back pain, these results suggest medical cannabis may reduce reliance on potentially harmful opioid medications while improving quality of life and functional capacity.